Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula.

Purpose: The US Food and Drug Administration (FDA) 2009 guidance for industry on patient-reported outcome (PRO) measures describes how the Agency evaluates the psychometric properties of measures intended to support medical product labeling claims. An important psychometric property is test-retest r...

Descripción completa

Detalles Bibliográficos
Publicado en:Quality of Life Research Vol. 28; no. 4; pp. 1029 - 1034
Autores principales: Qin, Shanshan, Nelson, Lauren, McLeod, Lori, Eremenco, Sonya, Coons, Stephen Joel
Formato: Journal Article
Publicado: Springer Nature Apr2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135607659&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 135607659
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09629343
        GPQ
      jtl: Quality of Life Research
      issn: 09629343
      maglogo: N
    pubinfo:
      dt: Apr2019
      vid: 28
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        135607659
        135607659
        NLM30547346
        10.1007/s11136-018-2076-0
        NLM30547346
        135607659
      ppf: 1029
      ppct: 5
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula.
      aug:
        au:
          Qin, Shanshan
          Nelson, Lauren
          McLeod, Lori
          Eremenco, Sonya
          Coons, Stephen Joel
        affil: RTI Health Solutions, 3040 Cornwallis Road, 27709, Research Triangle Park, NC, USA
      sug:
        subj:
          Psychometrics Methods
          Quality of Life Psychosocial Factors
          Female
          Reproducibility of Results
          Male
          Clinical Assessment Tools
          Female
          Male
      ab: Purpose: The US Food and Drug Administration (FDA) 2009 guidance for industry on patient-reported outcome (PRO) measures describes how the Agency evaluates the psychometric properties of measures intended to support medical product labeling claims. An important psychometric property is test-retest reliability. The guidance lists intraclass correlation coefficients (ICCs) and the assessment time period as key considerations for test-retest reliability evaluations. However, the guidance does not provide recommendations regarding ICC computation, nor is there consensus within the measurement literature regarding the most appropriate ICC formula for test-retest reliability assessment. This absence of consensus emerged as an issue within Critical Path Institute's PRO Consortium. The purpose of this project was to generate thoughtful and informed recommendations regarding the most appropriate ICC formula for assessing a PRO measure's test-retest reliability.Methods: Literature was reviewed and a preferred ICC formula was proposed. Feedback on the chosen formula was solicited from psychometricians, biostatisticians, regulators, and other scientists who have collaborated on PRO Consortium initiatives.Results and Conclusions: Feedback was carefully considered and, after further deliberation, the proposed ICC formula was confirmed. In conclusion, to assess test-retest reliability for PRO measures, the two-way mixed-effect analysis of variance model with interaction for the absolute agreement between single scores is recommended.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N